The International Coalition for Trachoma Control has produced a strategic plan that lays out the actions to take and the milestones to meet in order to achieve the global elimination of blinding trachoma by the year 2020.
“We can make this disease history, and this document lays out a plan to do so,” said Dr. Paul Emerson, chair of the ICTC and director of the Carter Center’s Trachoma Control Program. “There is an urgent need for action to avoid additional suffering and unnecessary blindness for hundreds of thousands of people.”
The International Trachoma Initiative (ITI) coordinated the publication of 2020 INSight, which was produced with input from a diverse set of stakeholders. McKinsey & Company, the independent management consulting firm, conducted in-depth interviews with representatives of national governments, international partners, and funders and provided comprehensive analysis to shape this global strategic plan.
Download 2020 INSight in French: Low res PDF 1.7 Mb
Funding was provided by Pfizer Inc., which has, since 1998, donated more than 225 million doses of the antibiotic Zithromax® to treat and prevent blinding trachoma. ITI manages distribution of the medicine.